KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Shares Outstanding (Diluted Average) (2016 - 2025)

Globus Medical (GMED) has disclosed Shares Outstanding (Diluted Average) for 13 consecutive years, with $137.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 0.59% year-over-year to $137.1 million, compared with a TTM value of $137.1 million through Dec 2025, down 0.59%, and an annual FY2025 reading of $137.1 million, down 0.59% over the prior year.
  • Shares Outstanding (Diluted Average) was $137.1 million for Q4 2025 at Globus Medical, down from $137.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $137.9 million in Q4 2024 and bottomed at $114.6 million in Q4 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $129.8 million, with a median of $137.1 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Diluted Average) rose 20.27% in 2024, then decreased 0.59% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $114.6 million in 2023, then rose by 20.27% to $137.9 million in 2024, then dropped by 0.59% to $137.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for GMED at $137.1 million in Q4 2025, $137.9 million in Q4 2024, and $114.6 million in Q4 2023.